1. Inicio
  2. Publicaciones
  3. Endovascular Treatment of Descending Thoracic Aortic Pathology: Results of the Regis-TEVAR Study

Endovascular Treatment of Descending Thoracic Aortic Pathology: Results of the Regis-TEVAR Study

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Espada, CL
  • Palomino, JPL
  • Gonzalez, JMD
  • Ortega, EI
  • Vilardell, PL
  • Valldaura, TS
  • Perez, GV
  • Canibano, EB
  • Salgado, AA
  • Fernandez, JCF
  • Rydings, MH

Grupos

Abstract

Background: Endovascular techniques have become an essential tool for treatment of thoracic aortic pathology. The objective of this study was to analyze indications and results of thoracic endovascular aortic repair (TEVAR) in vascular surgery units, through a retrospective and multicentric national registry called Regis-TEVAR. Methods: From 2012 to 2016, a total of 287 patients from 11 vascular surgery units, treated urgently and electively, were recruited consecutively. The primary variables analyzed are mortality, survival, and reintervention rate. The following indications for TEVAR were also analyzed: aortic dissections, thoracic aneurysms, traumatisms, and intramural hematomas or penetrating ulcers, as well as results and postoperative complications in accordance with each indication. Results: Of the 287 TEVAR performed (239 men, mean age 64.1 +/- 14.1 years), 155 were because of aortic aneurysm (54%), 90 because of type B aortic dissection (31.4%), 36 because of traumatic aortic rupture (12.5%), and 6 because of penetrating ulcers or intramural hematomas (2.1%). Overall mortality at 30 days was 11.5% (18.5% in urgent and 5.3% in elective), being higher in dissections (13.3%). The median actuarial survival was 73% at 4 years. The stroke rate was 3.1%, and the rate of spinal cord ischemia was 4.9%. Aortic reoperations were necessary in 23 patients (8.1%). Conclusions: This registry provides complete and reliable information on real clinical practice of TEVAR in Spain, with results similar to international series of open surgery. In accordance with these data, TEVAR can be performed with acceptable morbidity and mortality and with low rates of postoperative complications.

Datos de la publicación

ISSN/ISSNe:
0890-5096, 1615-5947

ANNALS OF VASCULAR SURGERY  ELSEVIER SCIENCE INC

Tipo:
Article
Páginas:
306-315
PubMed:
32173472
Factor de Impacto:
0,635 SCImago ℠
Cuartil:
Q2 SCImago ℠

Citas Recibidas en Web of Science: 3

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Campos de Estudio

Compartir